Transcend Therapeutics

Series-A
transcendtherapeutics.com Biotech & Healthcare
Total Funding $40M
Latest Round $40M Series-A
Last Announced Mar 26, 2023
Investors Undisclosed
Decision Makers 5 Available

About Transcend Therapeutics

Developing Rapid-Acting Treatments For Neuropsychiatric Diseases

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $40,000,000 · Series-A

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Transcend Therapeutics.

Funding History

1 Round
Series-A equity · Mar 26, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts